On the occasion of the first DIA BioVenture day on 28 March 2017 in Glasgow, Menno Aarnout, Wolfgang Stoiber and EBE's Barbara Freischem discussed options for solutions to support the development and funding of Advanced Therapies and Breakthrough Medicines in Europe.
Listen to the podcast here
Menno Aarnout Barbara Freischem Wolfgang Stoiber
Executive Director Executive Director Managing Director
The International Association European Biopharmaceutical JSB Partners
of Mutual Benefit Societies (AIM) Enterprises (EBE)
Discussions moderated by:
Vital TransformationSee also the EBE Position Paper 'Europe's flawed and underfunded biotech ecosystem